170537 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Protease inhibitors; Endopeptidase (E.C. 3.4.21-99) inhibitors; Serine protease (E.C. 3.4.21) inhibitors Serpins
Sub-classes:METHODS FOR PREDICTING THE RISK OF DEVELOPING MULTISYSTEM INFLAMMATORY SYNDROME (MIS) FOLLOWING EXPOSURE TO AN INFECTIOUS AGENT AND FOR DIAGNOSING MIS FOLLOWING EXPOSURE TO AN INFECTIOUS AGENT
#2EX VIVO MODEL OF INFLAMED HUMAN SKIN AND USES THEREOF FOR SCREENING ANTI-INFLAMMATORY COMPOUNDS
#3COAGULATION AND FIBRINOLYSIS ASSAYS
#4EVALUATION, ASSAYS AND TREATMENT OF PKALMEDIATED DISORDERS
#5METHODS AND SYSTEMS FOR IDENTIFYING MODULATORS OF PERVASIVE DEVELOPMENTAL DISORDERS
#6BIOMARKERS FOR DETERMINING SURVIVAL AND THERAPEUTIC RESPONSE IN CERVICAL CANCER
#7Evaluation, assays and treatment of pKal-mediated disorders
#8COAGULATION AND FIBRINOLYSIS ASSAYS
#9EXTRACELLULAR VESICLE MARKERS FOR STABLE ANGINA AND UNSTABLE ANGINA
#10COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#11COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#12Cardiovascular risk event prediction and uses thereof
#13METHODS OF DETERMINING RISK OF CARDIAC ARRHYTHMIA
#14METHOD TO PREDICT OR DIAGNOSE A COLORECTAL CANCER
#15INHIBITING CANCER METASTASIS
#16METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE
#17COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES OF INFECTIOUS AND NON-INFECTIOUS ORIGIN
#18Assays for determining levels of plasma protease C1 inhibitor
#19EPITHELIAL OVARIAN CANCER DIFFERENTIATION MARKER
#20ASSAYS FOR DETECTION OF GLYCOSAMINOGLYCANS
#21Methods, peptides, and biosensors useful for detecting a broad spectrum of bacteria
#22Renal Cell Carcinoma Biomarkers and Uses Thereof
#23METHODS AND PRODUCTS RELATED TO LUNG CANCER
#24ENDOTHELIAL CELLS ACTIVATION BIOMARKERS CHARACTERIZING ANTIBODY MEDIATED REJECTION AND USES THEREOF
#25COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#26INTRAVENOUS IMMUNOGLOBULIN PROCESSING, DIAGNOSTIC, AND TREATMENT SYSTEMS AND METHODS
#27Renal Cell Carcinoma Biomarkers and Uses Thereof
#28Determination of Exosomel Biomarkers for Predicting Cardiovascular Events
#29Serpin B 13 as a marker for squamous cell carcinoma of the lung
#30Assessment of patients with sepsis to determine a requirement for therapeutic intervention with an anti-inflammatory and/or anticoagulatory agent
#31Protein C inhibitor as a biomarker for prostate cancer
#32Method of Correlating Marker Molecule Concentration To A Specific Cell Potency Level in Chondrocyte Culture
#33Companion diagnostic assays for endothelin receptor antagonists
#34Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
#35Protein CBP2 as a marker for colorectal cancer
#36Human serpin polypeptides
#37Use of PRN3/ILEU as a marker for colorectal cancer
#38Human serpin polypeptides